89 related articles for article (PubMed ID: 12527996)
1. Effect of myasthenic immunoglobulin G on motor end-plate morphology.
Tsujihata M; Satoh A; Yoshimura T; Motomura M; Takeo G; Matsuo H; Nakamura T
J Neurol; 2003 Jan; 250(1):75-82. PubMed ID: 12527996
[TBL] [Abstract][Full Text] [Related]
2. Passively transferred experimental autoimmune myasthenia gravis. Sequential and quantitative study of the motor end-plate fine structure and ultrastructural localization of immune complexes (IgG and C3), and of the acetylcholine receptor.
Engel AG; Sakakibara H; Sahashi K; Lindstrom JM; Lambert EH; Lennon VA
Neurology; 1979 Feb; 29(2):179-88. PubMed ID: 571062
[TBL] [Abstract][Full Text] [Related]
3. Acetylcholine receptors loss and postsynaptic damage in MuSK antibody-positive myasthenia gravis.
Shiraishi H; Motomura M; Yoshimura T; Fukudome T; Fukuda T; Nakao Y; Tsujihata M; Vincent A; Eguchi K
Ann Neurol; 2005 Feb; 57(2):289-93. PubMed ID: 15668981
[TBL] [Abstract][Full Text] [Related]
4. The immunopathology of acquired myasthenia gravis.
Engel AG; Sahashi K; Fumagalli G
Ann N Y Acad Sci; 1981; 377():158-74. PubMed ID: 6951470
[TBL] [Abstract][Full Text] [Related]
5. Immune complexes (IgG and C3) at the motor end-plate in myasthenia gravis: ultrastructural and light microscopic localization and electrophysiologic correlations.
Engel AG; Lambert EH; Howard FM
Mayo Clin Proc; 1977 May; 52(5):267-80. PubMed ID: 870771
[TBL] [Abstract][Full Text] [Related]
6. [Study of antibodies to motor end-plate in ocular myasthenia gravis].
Kinoshita I; Tsujihata M; Motomura M; Yoshimura T; Nagataki S
Rinsho Shinkeigaku; 1991 May; 31(5):500-4. PubMed ID: 1934762
[TBL] [Abstract][Full Text] [Related]
7. Ultrastructural aspects of acetylcholine receptor turnover at the normal end-plate and in autoimmune myasthenia gravis.
Fumagalli G; Engel AG; Lindstrom J
J Neuropathol Exp Neurol; 1982 Nov; 41(6):567-79. PubMed ID: 6982313
[TBL] [Abstract][Full Text] [Related]
8. Refractoriness to a second episode of experimental myasthenia gravis. Correlation with AChR concentration and morphologic appearance of the postsynaptic membrane.
Corey AL; Richman DP; Agius MA; Wollmann RL
J Immunol; 1987 May; 138(10):3269-75. PubMed ID: 3494763
[TBL] [Abstract][Full Text] [Related]
9. Passively transferred myasthenia gravis: protection of mouse endplates by Fab fragments from human myasthenic IgG.
Toyka KV; Löwenadler B; Heininger K; Besinger UA; Birnberger KL; Fateh-Moghadam A; Heilbronn E
J Neurol Neurosurg Psychiatry; 1980 Sep; 43(9):836-42. PubMed ID: 6252294
[TBL] [Abstract][Full Text] [Related]
10. Myasthenia gravis: demonstration of membrane attack complex in muscle end-plates.
Fazekas A; Komoly S; Bózsik B; Szobor A
Clin Neuropathol; 1986; 5(2):78-83. PubMed ID: 3519034
[TBL] [Abstract][Full Text] [Related]
11. Structure-function correlations in myasthenia gravis and a new myasthenic syndrome.
Engel AG; Lambert EH
Electroencephalogr Clin Neurophysiol Suppl; 1978; (34):469-77. PubMed ID: 220007
[TBL] [Abstract][Full Text] [Related]
12. Effector mechanisms in myasthenia gravis: end-plate function after passive transfer of IgG, Fab, and F(ab')2 hybrid molecules.
Sterz R; Hohlfeld R; Rajki K; Kaul M; Heininger K; Peper K; Toyka KV
Muscle Nerve; 1986 May; 9(4):306-12. PubMed ID: 2423869
[TBL] [Abstract][Full Text] [Related]
13. Myasthenogenicity of a human acetylcholine receptor alpha-subunit peptide: morphology and immunology.
Matsuo H; Tsujihata M; Satoh A; Takeo G; Yoshimura T; Nagataki S
Muscle Nerve; 1992 Mar; 15(3):282-7. PubMed ID: 1372965
[TBL] [Abstract][Full Text] [Related]
14. Passive transfer of myasthenia gravis by immunoglobulins: lack of correlation between AChR with antibody bound, acetylcholine receptor loss and transmission defect.
Mossman S; Vincent A; Newsom-Davis J
J Neurol Sci; 1988 Mar; 84(1):15-28. PubMed ID: 2835437
[TBL] [Abstract][Full Text] [Related]
15. Effect of myasthenic IgG on degradation of junctional acetylcholine receptor.
Takeo G; Motomura M; Mats H; Ohishi K; Yoshimura T; Tsujihata M; Nagataki S
Muscle Nerve; 1993 Aug; 16(8):840-8. PubMed ID: 8332137
[TBL] [Abstract][Full Text] [Related]
16. Semiquantitative measurement of acetylcholine receptor at the motor end-plate in myasthenia gravis.
Tsujihata M; Ito H; Satoh A; Yoshimura T; Motomura M; Nakamura T
Intern Med; 2001 May; 40(5):376-81. PubMed ID: 11393405
[TBL] [Abstract][Full Text] [Related]
17. The immunopathological basis of acetylcholine receptor deficiency in myasthenia gravis.
Engel AG
Prog Brain Res; 1979; 49():423-34. PubMed ID: 515440
[No Abstract] [Full Text] [Related]
18. Acetylcholine release in myasthenia gravis: regulation at single end-plate level.
Plomp JJ; Van Kempen GT; De Baets MB; Graus YM; Kuks JB; Molenaar PC
Ann Neurol; 1995 May; 37(5):627-36. PubMed ID: 7755358
[TBL] [Abstract][Full Text] [Related]
19. Ultrastructural localization of immune complexes (IgG and C3) at the end-plate in experimental autoimmune myasthenia gravis.
Sahashi K; Engel AG; Linstrom JM; Lambert EH; Lennon VA
J Neuropathol Exp Neurol; 1978; 37(2):212-23. PubMed ID: 147324
[TBL] [Abstract][Full Text] [Related]
20. Morphologic and immunopathologic findings in myasthenia gravis and in congenital myasthenic syndromes.
Engel AG
J Neurol Neurosurg Psychiatry; 1980 Jul; 43(7):577-89. PubMed ID: 6249893
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
